Drug Profile
Carbon monoxide inhalation - Proterris
Alternative Names: iCO; iCO - ProterrisLatest Information Update: 14 Oct 2021
Price :
$50
*
At a glance
- Originator Proterris
- Class Anti-inflammatories; Inorganic carbon compounds; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute kidney injury; Delayed graft function; Idiopathic pulmonary fibrosis; Renal fibrosis
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for preclinical development in Delayed-graft-function in Portugal (Inhalation)
- 28 Jun 2021 No recent reports of development identified for preclinical development in Idiopathic-pulmonary-fibrosis in Portugal (Inhalation)
- 28 Jun 2021 No recent reports of development identified for research development in Acute kidney injury in Portugal (Inhalation)